Clinical trials
Active, not recruiting Phase 1 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 12 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 4 |
| Eli Lilly and Company | 4 |
| Hoffmann-La Roche | 3 |
| Novo Nordisk A/S | 3 |
| AdventHealth Translational Research Institute | 2 |
| AstraZeneca | 2 |
| CSPC Ouyi Pharmaceutical Co., Ltd. | 2 |
| University of Connecticut | 2 |
| Alveus Therapeutics, Inc. | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 35 |
| Overweight | 20 |
| Diabetes Mellitus, Type 2 | 5 |
| Weight Loss | 2 |
| Diabetes Mellitus | 1 |
| Dyslipidemias | 1 |
| Insulin Resistance | 1 |
| Prediabetic State | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.